ATC code J02
| ATC codes | |||
|---|---|---|---|
| J Antiinfectives for systemic use | |||
| J01 Antibacterials for systemic use | |||
| J02 Antimycotics for systemic use | |||
| J04 Antimycobacterials | |||
| J05 Antivirals for systemic use | |||
| Human only | |||
| J06 Immune sera and immunoglobulins | |||
| J07 Vaccines | |||
| ATCvet only | |||
| QJ51 Antibacterials for intramammary use | |||
| QJ54 Antimycobacterials for intramammary use | |||
|
| |||
ATC code J02 Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup J02 is part of the anatomical group J Antiinfectives for systemic use.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QJ02...[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J02A Antimycotics for systemic use
J02AA Antibiotics
- J02AA01 Amphotericin B
- J02AA02 Hachimycin
J02AB Imidazole derivatives
- J02AB01 Miconazole
- J02AB02 Ketoconazole
- QJ02AB90 Clotrimazole
J02AC Triazole derivatives
- J02AC01 Fluconazole
- J02AC02 Itraconazole
- J02AC03 Voriconazole
- J02AC04 Posaconazole
- J02AC05 Isavuconazole
J02AX Other antimycotics for systemic use
- J02AX01 Flucytosine
- J02AX04 Caspofungin
- J02AX05 Micafungin
- J02AX06 Anidulafungin
References
- ↑ "ATC/DDD Index 2016: code J02". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2016: code QJ02". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia - version of the Wednesday, January 06, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.